HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells

eLife

Volumn 4, Issue OCTOBER2015, 2015, Pages

  Reeder, Jonathan E ^a,b   Kwak, Youn Tae ^b   McNamara, Ryan P ^b   Forst, Christian V ^c   D’Orso, Iván ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CD69 ANTIGEN; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INITIATION FACTOR 3; PROTEIN KINASE LCK; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FLOW CYTOMETRY; GENE LOOPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; MOLECULAR GENETICS; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; RNA SEQUENCE; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; WESTERN BLOTTING; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HIV; HOST-PATHOGEN INTERACTIONS; HUMANS; RNA POLYMERASE II; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC;

EID: 84955308114     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.08955     Document Type: Article

References (112)

1. Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nature Reviews. Genetics 13:720-731. doi: 10.1038/nrg3293
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. the gene ontology consortium. Nature Genetics 25:25-29. doi: 10.1038/75556
3. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren J, Li WW, Noble WS. 2009. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Research 37:W202-W208. doi: 10.1093/nar/gkp335
4. Bailey TL. 2011. DREME: motif discovery in transcription factor ChIP-seq data. Bioinformatics 27:1653-1659. doi: 10.1093/bioinformatics/btr261
5. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129:823-837. doi: 10.1016/j.cell.2007.05.009
6. Bernstein BE, Humphrey EL, Erlich RL, Schneider R, Bouman P, Liu JS, Kouzarides T, Schreiber SL. 2002. Methylation of histone H3 lys 4 in coding regions of active genes. Proceedings of the National Academy of Sciences 99:8695-8700. doi: 10.1073/pnas.082249499
7. Bosque A, Planelles V. 2011. Studies of HIV-1 latency in an ex vivo model that uses primary central memory t cells. Methods 53:54-61. doi: 10.1016/j.ymeth.2010.10.002
8. Bulger M, Groudine M. 2011. Functional and mechanistic diversity of distal transcription enhancers. Cell 144: 327-339. doi: 10.1016/j.cell.2011.01.024
9. Cabusora L, Sutton E, Fulmer A, Forst CV. 2005. Differential network expression during drug and stress response. Bioinformatics 21:2898-2905. doi: 10.1093/bioinformatics/bti440
10. Caldwell RL, Egan BS, Shepherd VL. 2000. HIV-1 tat represses transcription from the mannose receptor promoter. Journal of Immunology 165:7035-7041. doi: 10.4049/jimmunol.165.12.7035
11. Core LJ, Lis JT. 2008. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science 319:1791-1792. doi: 10.1126/science.1150843
12. Core LJ, Waterfall JJ, Lis JT. 2008. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science (New York, N.Y.) 322:1845-1848. doi: 10.1126/science.1162228
13. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R, Lodato MA, Frampton GM, Sharp PA, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proceedings of the National Academy of Sciences 107:21931-21936. doi: 10.1073/pnas.1016071107
14. Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, Caudy M, Garapati P, Gillespie M, Kamdar MR, Jassal B, Jupe S, Matthews L, May B, Palatnik S, Rothfels K, Shamovsky V, Song H, Williams M, Birney E, Hermjakob H, Stein L, D'Eustachio P. 2014. The reactome pathway knowledgebase. Nucleic Acids Research 42:D472-D477. doi: 10.1093/nar/gkt1102
15. D'Orso I, Frankel AD. 2010. RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation. Nature Structural & Molecular Biology 17:815-821. doi: 10.1038/nsmb.1827
16. D'Orso I, Jang GM, Pastuszak AW, Faust TB, Quezada E, Booth DS, Frankel AD. 2012. Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA. Molecular and Cellular Biology 32:4780-4793. doi: 10.1128/MCB.00206-12
17. Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research 11:1475-1489. doi: 10.1093/nar/11.5.1475
18. Egelhofer TA, Minoda A, Klugman S, Lee K, Kolasinska-Zwierz P, Alekseyenko AA, Cheung MS, Day DS, Gadel S, Gorchakov AA, Gu T, Kharchenko PV, Kuan S, Latorre I, Linder-Basso D, Luu Y, Ngo Q, Perry M, Rechtsteiner A, Riddle NC, Schwartz YB, Shanower GA, Vielle A, Ahringer J, Elgin SC, Kuroda MI, Pirrotta V, Ren B, Strome S, Park PJ, Karpen GH, Hawkins RD, Lieb JD. 2011. An assessment of histone-modification antibody quality. Nature Structural & Molecular Biology 18:91-93. doi: 10.1038/nsmb.1972
19. ENCODE Project Consortium. 2011. A user's guide to the encyclopedia of DNA elements (eNCODE). PLoS Biology 9:e1001046 doi: 10.1371/journal.pbio.1001046
20. Feinberg MB, Baltimore D, Frankel AD. 1991. The role of tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proceedings of the National Academy of Sciences 88: 4045-4049. doi: 10.1073/pnas.88.9.4045
21. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK. 2008. Epigenetic reprogramming by adenovirus e1a. Science 321:1086-1088. doi: 10.1126/science.1155546
22. Frankel AD, Bredt DS, Pabo CO. 1988. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240:70-73. doi: 10.1126/science.2832944
23. Frankel AD, Young JA. 1998. HIV-1: fifteen proteins and an RNA. Annual Review of Biochemistry 67:1-25. doi: 10.1146/annurev.biochem.67.1.1
24. Fuda NJ, Ardehali MB, Lis JT. 2009. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461:186-192. doi: 10.1038/nature08449
25. Ghavi-Helm Y, Klein FA, Pakozdi T, Ciglar L, Noordermeer D, Huber W, Furlong EE. 2014. Enhancer loops appear stable during development and are associated with paused polymerase. Nature 512:96-100. doi: 10. 1038/nature13417
26. Goel R, Muthusamy B, Pandey A, Prasad TS. 2011. Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology. Molecular Biotechnology 48:87-95. doi: 10.1007/s12033- 010-9336-8
27. Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, Espinosa JM. 2006. Gene-specific requirement for p- TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes & Development 20:601-612. doi: 10.1101/gad.1398206
28. Grünberg S, Hahn S. 2013. Structural insights into transcription initiation by RNA polymerase II. Trends in Biochemical Sciences 38:603-611. doi: 10.1016/j.tibs.2013.09.002
29. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130:77-88. doi: 10.1016/j.cell.2007.05.042
30. Guttman M, Rinn JL. 2012. Modular regulatory principles of large non-coding RNAs. Nature 482:339-346. doi: 10.1038/nature10887
31. Hagège H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, de Laat W, FornéT. 2007. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nature Protocols 2:1722-1733. doi: 10.1038/nprot.2007. 243
32. Hah N, Murakami S, Nagari A, Danko CG, Kraus WL. 2013. Enhancer transcripts mark active estrogen receptor binding sites. Genome Research 23:1210-1223. doi: 10.1101/gr.152306.112
33. Hahn S. 2004. Structure and mechanism of the RNA polymerase II transcription machinery. Nature Structural & Molecular Biology 11:394-403. doi: 10.1038/nsmb763
34. Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D. 2000. T-cell division in human immunodeficiency virus (hIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (hAART). Blood 95:249-255.
35. He N, Liu M, Hsu J, Xue Y, Chou S, Burlingame A, Krogan NJ, Alber T, Zhou Q. 2010. HIV-1 tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Molecular Cell 38:428-438. doi: 10.1016/j.molcel.2010.04.013
36. He Q, Johnston J, Zeitlinger J. 2015. ChIP-nexus enables improved detection of in vivo transcription factor binding footprints. Nature Biotechnology 33:395-401. doi: 10.1038/nbt.3121
37. Heintzman ND, Ren B. 2009. Finding distal regulatory elements in the human genome. Current Opinion in Genetics & Development 19:541-549. doi: 10.1016/j.gde.2009.09.006
38. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B, Ching CW, Hawkins RD, Barrera LO, van Calcar S, Qu C, Ching KA, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genetics 39:311-318. doi: 10.1038/ng1966
39. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and b cell identities. Molecular Cell 38:576-589. doi: 10.1016/j.molcel.2010.05.004
40. Hellerstein MK, Hoh RA, Hanley MB, Cesar D, Lee D, Neese RA, Mccune JM. 2003. Subpopulations of long-lived and short-lived t cells in advanced HIV-1 infection. Journal of Clinical Investigation 112:956-966. doi: 10.1172/ JCI200317533
41. Hollenhorst PC, Chandler KJ, Poulsen RL, Johnson WE, Speck NA, Graves BJ, Snyder M. 2009. DNA specificity determinants associate with distinct transcription factor functions. PLoS Genetics 5:e1000778 doi: 10.1371/ journal.pgen.1000778.s005
42. Hollenhorst PC, Mcintosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annual Review of Biochemistry 80:437-471. doi: 10.1146/annurev.biochem.79.081507. 103945
43. Horwitz GA, Zhang K, Mcbrian MA, Grunstein M, Kurdistani SK, Berk AJ. 2008. Adenovirus small e1a alters global patterns of histone modification. Science 321:1084-1085. doi: 10.1126/science.1155544
44. Hottiger MO, Nabel GJ. 1998. Interaction of human immunodeficiency virus type 1 tat with the transcriptional coactivators p300 and CREB binding protein. Journal of Virology 72:8252-8256.
45. Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB. 1998. Tat protein induces human immunodeficiency virus type 1 (hIV-1) coreceptors and promotes infection with both macrophage-tropic and t-lymphotropic HIV-1 strains. Journal of Virology 72:8952-8960.
46. Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A. 2003. HIV-1 tat reprograms immature dendritic cells to express chemoattractants for activated t cells and macrophages. Nature Medicine 9:191-197. doi: 10.1038/nm822
47. Jager S, Cimermancic P, Gulbahce N, Johnson JR, Mcgovern KE, Clarke SC, Shales M, Mercenne G, Pache L, Li K, et al. 2012. Global landscape of HIV-human protein complexes. Nature 481:365-370.
48. Jin F, Li Y, Dixon JR, Selvaraj S, Ye Z, Lee AY, Yen C-A, Schmitt AD, Espinoza CA, Ren B. 2013. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503:290-294 doi: 10.1038/ nature12644. doi: 10.1038/nature12644
49. Kao S-Y, Calman AF, Luciw PA, Peterlin BM. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-493. doi: 10.1038/330489a0
50. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, Chen C, Duesbury M, Dumousseau M, Feuermann M, Hinz U, Jandrasits C, Jimenez RC, Khadake J, Mahadevan U, Masson P, Pedruzzi I, Pfeiffenberger E, Porras P, Raghunath A, Roechert B, Orchard S, Hermjakob H, Duesbury M, Dumousseau M, Feuermann M, Hinz U, et al. 2012. The IntAct molecular interaction database in 2012. Nucleic Acids Research 40:D841-D846. doi: 10. 1093/nar/gkr1088
51. Kim N, Kukkonen S, Gupta S, Aldovini A, Rice AP. 2010a. Association of tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ t cells. PLoS Pathogens 6:e1001103 doi: 10.1371/journal.ppat.1001103.s003
52. Kim N, Kukkonen S, Martinez-Viedma MDP, Gupta S, Aldovini A. 2013. Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells. Blood 121:4090-4100. doi: 10.1182/blood-2012-10-461566
53. Kim T-K, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, Markenscoff-Papadimitriou E, Kuhl D, Bito H, Worley PF, Kreiman G, Greenberg ME, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465:182-187. doi: 10.1038/nature09033
54. Kim T-K, Shiekhattar R. 2015. Architectural and functional commonalities between enhancers and promoters. Cell 162:948-959. doi: 10.1016/j.cell.2015.08.008
55. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. 2009. Differential chromatin marking of introns and expressed exons by H3K36me3. Nature Genetics 41:376-381. doi: 10.1038/ng.322
56. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705. doi: 10.1016/j.cell.2007.02. 005
57. Kowalczyk Monika S., Hughes Jim R., Garrick D, Lynch Magnus D., Sharpe Jacqueline A., Sloane-Stanley Jacqueline A., Mcgowan Simon J., de Gobbi M, Hosseini M, Vernimmen D, Brown Jill M., Gray Nicola E., Collavin L, Gibbons Richard J., Flint J, Taylor S, Buckle Veronica J., Milne Thomas A., Wood William G., Higgs Douglas R., et al. 2012. Intragenic enhancers act as alternative promoters. Molecular Cell 45:447-458. doi: 10. 1016/j.molcel.2011.12.021
58. Krogan NJ, Dover J, Wood A, Schneider J, Heidt J, Boateng MA, Dean K, Ryan OW, Golshani A, Johnston M, Greenblatt JF, Shilatifard A, et al. 2003. The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Molecular Cell 11:721-729. doi: 10.1016/ S1097-2765(03)00091-1
59. Krogan NJ, Kim M, Tong A, Golshani A, Cagney G, Canadien V, Richards DP, Beattie BK, Emili A, Boone C, Shilatifard A, Buratowski S, Greenblatt J, et al. 2003. Methylation of histone H3 by Set2 in saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Molecular and Cellular Biology 23: 4207-4218. doi: 10.1128/MCB.23.12.4207-4218.2003
60. Kukkonen S, Martinez-Viedma MD, Kim N, Manrique M, Aldovini A. 2014. HIV-1 tat second exon limits the extent of tat-mediated modulation of interferon-stimulated genes in antigen presenting cells. Retrovirology 11: 30 doi: 10.1016/0003-2697(81)90281-5
61. König R, Stertz S, Zhou Y, Inoue A, Hoffmann H-H, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, de Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, García-Sastre A, Young JAT, Palese P, Shaw ML, Chanda SK, et al. 2010. Human host factors required for influenza virus replication. Nature 463:813-817. doi: 10.1038/nature08699
62. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 10:R25 doi: 10.1186/gb-2009-10-3-r25
63. Laspia MF, Rice AP, Mathews MB. 1989. HIV-1 tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292. doi: 10.1016/0092-8674(89)90290-0
64. Lau A, Swinbank KM, Ahmed PS, Taylor DL, Jackson SP, Smith GCM, O'Connor MJ. 2005. Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nature Cell Biology 7:493-500. doi: 10.1038/ ncb1250
65. Li B, Carey M, Workman JL. 2007. The role of chromatin during transcription. Cell 128:707-719. doi: 10.1016/j. cell.2007.01.015
66. Li CJ, Ueda Y, Shi B, Borodyansky L, Huang L, Li Y-Z, Pardee AB. 1997. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proceedings of the National Academy of Sciences 94:8116-8120. doi: 10.1073/pnas.94.15.8116
67. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R.1000 Genome Project Data Processing SubgroupGenome Project Data Processing, S. 2009. The sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079. doi: 10.1093/bioinformatics/btp352
68. Lopez-Huertas MR, Callejas S, Abia D, Mateos E, Dopazo A, Alcami J, Coiras M. 2010. Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 tat protein are greatly dependent on the second coding exon. Nucleic Acids Research 38:3287-3307. doi: 10.1093/nar/gkq037
69. Lorenz R, Bernhart SH, Höner Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL. 2011. ViennaRNA package 2.0. Algorithms for Molecular Biology 6:26 doi: 10.1016/0005-2795(75)90109-9
70. Luo Z, Lin C, Shilatifard A. 2012. The super elongation complex (sEC) family in transcriptional control. Nature Reviews Molecular Cell Biology 13:543-547. doi: 10.1038/nrm3417
71. Mancebo HSY, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D, Flores O, et al.1997. P-TEFb kinase is required for HIV tat transcriptional activation in vivo and in vitro. Genes & Development 11:2633-2644. doi: 10.1101/gad.11.20.2633
72. Marazzi I, Ho JSY, Kim J, Manicassamy B, Dewell S, Albrecht RA, Seibert CW, Schaefer U, Jeffrey KL, Prinjha RK, Lee K, García-Sastre A, Roeder RG, Tarakhovsky A, Manicassamy B, Dewell S, Albrecht RA, Seibert CW, Schaefer U, Jeffrey KL, Prinjha RK, et al. 2012. Suppression of the antiviral response by an influenza histone mimic. Nature 483:428-433. doi: 10.1038/nature10892
73. Marban Céline, Su T, Ferrari R, Li B, Vatakis D, Pellegrini M, Zack JA, Rohr O, Kurdistani SK, Rossi JJ, Vatakis D, Pellegrini M, Zack JA, Rohr O, Kurdistani SK. 2011. Genome-wide binding map of the HIV-1 tat protein to the human genome. PLoS ONE 6:e26894 doi: 10.1371/journal.pone.0026894.s001
74. Martin C, Zhang Y. 2005. The diverse functions of histone lysine methylation. Nature Reviews Molecular Cell Biology 6:838-849. doi: 10.1038/nrm1761
75. Mata MA, Satterly N, Versteeg GA, Frantz D, Wei S, Williams N, Schmolke M, Peña-Llopis S, Brugarolas J, Forst CV, White MA, García-Sastre A, Roth MG, Fontoura BMA, et al. 2011. Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. Nature Chemical Biology 7:712-719. doi: 10.1038/nchembio.645
76. Mayer A, di Iulio J, Maleri S, Eser U, Vierstra J, Reynolds A, Sandstrom R, Stamatoyannopoulos John A., Churchman L S. 2015. Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution. Cell 161:541-554. doi: 10.1016/j.cell.2015.03.010
77. Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. 2009. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324:407-410. doi: 10.1126/science.1164265
78. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F. 2003. Memory and flexibility of cytokine gene expression as separable properties of human TH1 and TH2 lymphocytes. Nature Immunology 4:78-86. doi: 10.1038/ni872
79. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim T-K, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, et al. 2007. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560. doi: 10.1038/nature06008
80. Min IM, Waterfall JJ, Core LJ, Munroe RJ, Schimenti J, Lis JT. 2011. Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells. Genes & Development 25:742-754. doi: 10.1101/gad. 2005511
81. Nguyen AT, Zhang Y. 2011. The diverse functions of Dot1 and H3K79 methylation. Genes & Development 25: 1345-1358. doi: 10.1101/gad.2057811
82. Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, Lander ES, Armstrong SA, Daley GQ, et al. 2012. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483:598-602. doi: 10.1038/nature10953
83. Ott M, Geyer M, Zhou Q. 2011. The control of HIV transcription: keeping RNA polymerase II on track. Cell Host & Microbe 10:426-435. doi: 10.1016/j.chom.2011.11.002
84. Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, Karn J. 2008. Epigenetic silencing of human immunodeficiency virus (hIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. Journal of Virology 82:12291-12303. doi: 10. 1128/JVI.01383-08
85. Peterlin BM, Price DH. 2006. Controlling the elongation phase of transcription with p-TEFb. Molecular Cell 23: 297-305. doi: 10.1016/j.molcel.2006.06.014
86. Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW, Walker K, Rolfe PA, Herbolsheimer E, Zeitlinger J, Lewitter F, Gifford DK, Young RA, et al. 2005. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122:517-527. doi: 10.1016/j.cell.2005.06.026
87. Raha T, Cheng SWG, Green MR, Kadonaga J. 2005. HIV-1 tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biology 3:e44 doi: 10.1371/journal.pbio.0030044.g006
88. Rahl PB, Lin CY, Seila AC, Flynn RA, Mccuine S, Burge CB, Sharp PA, Young RA. 2010. C-myc regulates transcriptional pause release. Cell 141:432-445. doi: 10.1016/j.cell.2010.03.030
89. Reppas NB, Wade JT, Church George M., Struhl K. 2006. The transition between transcriptional initiation and elongation in e. coli is highly variable and often rate limiting. Molecular Cell 24:747-757. doi: 10.1016/j.molcel. 2006.10.030
90. Rhee HS, Pugh BF. 2011. Comprehensive genome-wide protein-DNA interactions detected at single-nucleotide resolution. Cell 147:1408-1419. doi: 10.1016/j.cell.2011.11.013
91. Rice AP, Mathews MB. 1988. Transcriptional but not translational regulation of HIV-1 by the tat gene product. Nature 332:551-553. doi: 10.1038/332551a0
92. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nature Biotechnology 29:24-26. doi: 10.1038/nbt.1754
93. Sancho D, Gómez M, Sánchez-Madrid F. 2005. CD69 is an immunoregulatory molecule induced following activation. Trends in Immunology 26:136-140. doi: 10.1016/j.it.2004.12.006
94. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NCT, Schreiber SL, Mellor J, Kouzarides T. 2002. Active genes are tri-methylated at K4 of histone H3. Nature 419:407-411. doi: 10.1038/nature01080
95. Seila AC, Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA, Sharp PA. 2008. Divergent transcription from active promoters. Science 322:1849-1851. doi: 10.1126/science.1162253
96. Shilatifard A. 2012. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annual Review of Biochemistry 81:65-95. doi: 10.1146/annurev-biochem-051710- 134100
97. Shiryev SA, Papadopoulos JS, Schaffer AA, Agarwala R. 2007. Improved BLAST searches using longer words for protein seeding. Bioinformatics 23:2949-2951. doi: 10.1093/bioinformatics/btm479
98. Sims RJ, Belotserkovskaya R, Reinberg D.3rd. 2004. Elongation by RNA polymerase II: the short and long of it. Genes & Development 18:2437-2468. doi: 10.1101/gad.1235904
99. Smallwood A, Ren B. 2013. Genome organization and long-range regulation of gene expression by enhancers. Current Opinion in Cell Biology 25:387-394. doi: 10.1016/j.ceb.2013.02.005
100. Smith E, Shilatifard A. 2013. Transcriptional elongation checkpoint control in development and disease. Genes & Development 27:1079-1088. doi: 10.1101/gad.215137.113
101. Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, Benkirane M. 2010. HIV-1 tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Molecular Cell 38: 439-451. doi: 10.1016/j.molcel.2010.04.012
102. Stasevich TJ, Hayashi-Takanaka Y, Sato Y, Maehara K, Ohkawa Y, Sakata-Sogawa K, Tokunaga M, Nagase T, Nozaki N, Mcnally JG, Kimura H. 2014. Regulation of RNA polymerase II activation by histone acetylation in single living cells. Nature 516:272-275. doi: 10.1038/nature13714
103. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, et al. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences 102:15545-15550. doi: 10.1073/pnas.0506580102
104. Tessarz P, Kouzarides T. 2014. Histone core modifications regulating nucleosome structure and dynamics. Nature Reviews. Molecular Cell Biology 15:703-708. doi: 10.1038/nrm3890
105. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. 2013. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nature Biotechnology 31:46-53. doi: 10.1038/nbt.2450
106. Wade JT, Struhl K. 2008. The transition from transcriptional initiation to elongation. Current Opinion in Genetics & Development 18:130-136. doi: 10.1016/j.gde.2007.12.008
107. Weissman JD, Brown JA, Howcroft TK, Hwang J, Chawla A, Roche PA, Schiltz L, Nakatani Y, Singer DS. 1998. HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class i genes. Proceedings of the National Academy of Sciences 95:11601-11606. doi: 10.1073/pnas.95.20.11601
108. Zeitlinger J, Stark A, Kellis M, Hong JW, Nechaev S, Adelman K, Levine M, Young RA. 2007. RNA polymerase stalling at developmental control genes in the drosophila melanogaster embryo. Nature Genetics 39:1512- 1516. doi: 10.1038/ng.2007.26
109. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. 2008. Model-based analysis of ChIP-seq (mACS). Genome Biology 9:R137 doi: 10.1186/gb-2008-9-9-r137
110. Zhou Q, Li T, Price DH. 2012. RNA polymerase II elongation control. Annual Review of Biochemistry 81:119-143. doi: 10.1146/annurev-biochem-052610-095910
111. Zhou VW, Goren A, Bernstein BE. 2011. Charting histone modifications and the functional organization of mammalian genomes. Nature Reviews. Genetics 12:7-18. doi: 10.1038/nrg2905
112. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH. 1997. Transcription elongation factor p-TEFb is required for HIV-1 tat transactivation in vitro. Genes & Development 11:2622-2632. doi: 10.1101/gad.11.20.2622